TGF-β produced by Tregs can suppress allergic responses and prevent colitis in inflammatory bowel disease (IBD) models (50, 51), and IL-35, another inhibitory cytokine, is required for maximal Treg suppressive activity (52). This evidence concerns the gene TGFB1 and inflammatory bowel disease.